Royal Philips announced that it will feature the company’s latest Magnetic Resonance (MR) solutions and neurology-focused clinical applications at the International Society for Magnetic Resonance in Medicine’s (ISMRM) 25th annual meeting and exhibition in Hawaii. As a part of its newest suite of magnetic resonance (MR)-based software applications dedicated to neurology, Philips will be showcasing MultiBand SENSE, which was developed …

GenMark Diagnostics announced it has achieved CE Mark under the European In?Vitro Diagnostic Devices Directive (98/79/EC) for its ePlex Blood Culture Identification Fungal Pathogen (BCID-FP) Panel. BCID-FP is the first panel in the GenMark Sepsis Solution, which will also include BCID Gram-Positive and Gram-Negative panels. “We are very pleased to bring the first of our three blood culture identification panels …

Vivify Health, the pioneer and market leader of remote care via mobile devices, has been awarded a very significant patent for the advancement of healthcare delivery from episodic care via EMRs to continual care via digital health.  This landmark patent provides the company with broad protection of key intellectual property and further secures Vivify’s position as the leader in remote …

Deerfield Management announced its plan to acquire Adeptus Health with a long-term commitment to the delivery of high quality, efficient emergency care.  Deerfield is a 23 year-old firm focused on advancing healthcare through investment, information, and philanthropy.  With over $8 billion in assets, and industry leading investment, operations, and market research teams, Deerfield brings to Adeptus highly relevant expertise in …

Lifetrack Medical Systems announced US FDA approval of its Lifesys™ PACS, the first 4th generation PACS enabling truly distributed radiology for better healthcare. Already deployed in Southeast Asia and South Asia, Lifetrack’s patented platform is extending the reach of high quality medicine by greatly simplifying and speeding deployment of digital radiology, all while significantly reducing costs, and solving the greatest …

Cardinal Health announced that it has entered into a definitive agreement to acquire Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash. The purchase price does not include cash tax benefits of at least $100 million. The acquisition is expected to be financed with a combination of $4.5 billion in new senior unsecured notes …

After nearly a decade of research and development, BIOTRONIK announced the launch of Plexa ProMRI®, the smallest (7.8F) MR conditional tachycardia lead available in the United States. The US Food and Drug Administration (FDA) approved Plexa ProMRI on February 1, 2017 for use with implantable cardioverter defibrillators (ICDs) and heart failure devices. The lead’s performance-driven, high-voltage wire design maximizes durability …

Cardiovascular Systems, announced it has initiated a voluntary recall of its 7-10014 Saline Infusion Pump. CSI initiated a customer communication of the recall by letter and informed customers that they may continue to use the affected Saline Infusion Pumps until they receive a replacement. The Saline Infusion Pumps provide saline and lubricant infusion during orbital atherectomy procedures and electrical power …

Cellnovo Group announce the completion of a worldwide commercial license agreement for the integration and the commercialization of TypeZero’s Artificial Pancreas (AP) technology into Cellnovo’s mobile diabetes management systems. The non-exclusive worldwide agreement allows Cellnovo to commercialize a Cellnovo-TypeZero product in the future. Integration efforts are currently underway with a product launch expected in 2018. No financial terms have been …